| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.1780330807 |
| P698 | PubMed publication ID | 2202308 |
| P50 | author | Anthony Fauci | Q573246 |
| Leonard Calabrese | Q22277242 | ||
| Randi Y. Leavitt | Q125347107 | ||
| Mary Betty Stevens | Q125347132 | ||
| Dennis J. McShane | Q125347232 | ||
| P2093 | author name string | J. T. Lie | |
| Lie JT | |||
| Fries JF | |||
| Michel BA | |||
| Bloch DA | |||
| Calabrese LH | |||
| Hunder GG | |||
| Leavitt RY | |||
| Arend WP | |||
| Lightfoot RW Jr | |||
| William P. Arend | |||
| Daniel A. Bloch | |||
| James F. Fries | |||
| John A. Mills | |||
| Alfonse T. Masi | |||
| Beat A. Michel | |||
| Gene G. Hunder | |||
| Nathan J. Zvaifler | |||
| Robert W. Lightfoot | |||
| Stanley L. Wallace | |||
| P2860 | cites work | Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years | Q34055385 |
| Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis | Q41841296 | ||
| Serodiagnosis of Wegener's granulomatosis: pathobiologic and clinical implications | Q46106079 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1101-1107 | |
| P577 | publication date | 1990-08-01 | |
| 2010-08-17 | |||
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| Arthritis and Rheumatism | Q23929027 | ||
| P1476 | title | The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis | |
| The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis | |||
| P478 | volume | 33 |
| Q47566742 | 'In one ear and out the other - it's a lot to take in': a qualitative study exploring the informational needs of patients with ANCA-associated vasculitis |
| Q90177183 | A 60-year-old with heart failure symptoms due to 1st degree AV-Block caused by granulomatosis with polyangiitis (Wegener's granulomatosis) |
| Q35662632 | A Fulminant Case of Granulomatosis with Polyangiitis with Meningeal and Parenchymal Involvement. |
| Q48027615 | A boy with consecutive development of SLE and Wegener granulomatosis |
| Q40269806 | A case of (double) ANCA-negative granulomatosis with polyangiitis (Wegener's). |
| Q54583801 | A case of destructive Wegener's granulomatosis complicated by cytomegalovirus infection. |
| Q35226275 | A case of granulomatosis with polyangiitis preceded by subacute thyroiditis |
| Q43522388 | A case of strawberry gingivitis |
| Q42066166 | A case report of the orbit, ocular association and the lung in granulomatosis with polyangiitis: A diagnostic challenge |
| Q44523169 | A case report of wegener granulomatosis treated only with corticosteroids for 30 years |
| Q43272700 | A confusing patient's history: small or large vessel vasculitis? |
| Q48256152 | A diagnostic pitfall in IgG4-related hypophysitis: infiltration of IgG4-positive cells in the pituitary of granulomatosis with polyangiitis |
| Q79840093 | A new international classification of childhood vasculitis |
| Q34322432 | A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus. |
| Q35636989 | A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease |
| Q40002889 | A presentation of cerebritis secondary to granulomatosis with polyangiitis (wegener) |
| Q71756207 | A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis |
| Q36028139 | A surgical case of eosinophilic angiocentric fibrosis of the lung. |
| Q54357187 | AC13, a C-terminal fragment of apolipoprotein A-I, is a candidate biomarker for microscopic polyangiitis. |
| Q40868442 | ANCA and associated diseases: immunodiagnostic and pathogenetic aspects |
| Q30248761 | ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients |
| Q33644574 | ANCA-associated vasculitis in childhood: recent advances. |
| Q38071922 | ANCA-associated vasculitis: report from Korea |
| Q64984126 | ANCA-negative Granulomatosis with Polyangiitis: A Difficult Diagnosis. |
| Q62573899 | ANCA-negative subglottische Kehlkopf-Stenose im Kindesalter |
| Q93591832 | AUTHORS' REPLY |
| Q37600604 | Abnormal expression pattern of the IL-2 receptor β-chain on CD4+ T cells in ANCA-associated vasculitis. |
| Q48287381 | Accelerated atherosclerosis in ANCA-associated vasculitis. |
| Q35555500 | Accelerated atherosclerosis in patients with Wegener's granulomatosis |
| Q52055219 | Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. |
| Q71993240 | Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA |
| Q39003379 | Acute Cardiac Tamponade in a 58-Year-Old Male with Poststreptococcal Glomerulonephritis |
| Q64898820 | Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature. |
| Q48026996 | Acute hemorrhagic respiratory failure caused by Wegener's granulomatosis successfully treated by bronchoalveolar lavage with diluted surfactant |
| Q48822576 | Acute pachymeningitis mimicking subdural hematoma in a patient with polyarteritis nodosa |
| Q53229788 | Air trapping in Wegener's granulomatosis: an additional finding on expiratory chest HRCT. |
| Q37967656 | Airway manifestations in childhood granulomatosis with polyangiitis (Wegener's). |
| Q43851652 | Alpha 1-antitrypsin activity is markedly decreased in Wegener's granulomatosis |
| Q42187898 | Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases. |
| Q54398684 | Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener's granulomatosis. |
| Q34071051 | An unusual case of multiple cranial nerve palsies in Wegener's granulomatosis. |
| Q34523216 | An unusual cause for fever of unknown origin in a patient with a prosthetic valve |
| Q72403162 | An unusual skin lesion in a pediatric patient with Wegener's granulomatosis |
| Q26796566 | An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review |
| Q43616477 | Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up |
| Q51579316 | Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. |
| Q80826802 | Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome |
| Q67503399 | Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis |
| Q36974296 | Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. |
| Q51764280 | Anti-neutrophil cytoplasmic antibodies and their clinical significance. |
| Q40978265 | Anti-neutrophil cytoplasmic antibodies in primary small vessel vasculitides |
| Q40636649 | Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential |
| Q57453127 | Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature |
| Q77953526 | Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane |
| Q71433012 | Antibodies to neutrophil elastase: a study in patients with vasculitis |
| Q60957664 | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review |
| Q35260781 | Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis |
| Q35038822 | Antineutrophil cytoplasmic antibodies testing in a large cohort of unselected greek patients |
| Q41361340 | Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis |
| Q73090825 | Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa |
| Q99406726 | Aortic Involvement in Antineutrophil Cytoplasmic Antibodies Vasculitis, a Coincidence or a Real Association? |
| Q52013021 | Appropriateness of autoantibody testing in clinical medicine. |
| Q34449112 | Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune? |
| Q37126316 | Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from Colombia. |
| Q36310801 | Association between environmental exposures and granulomatosis with polyangiitis in Canterbury, New Zealand |
| Q48562190 | Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice? |
| Q39225213 | Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules |
| Q35754787 | Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis |
| Q64257234 | Association of serum high mobility group box 1 levels with disease activity and renal involvement in patients with systemic vasculitis |
| Q24806015 | Association study with Wegener granulomatosis of the human phospholipase Cgamma2 gene |
| Q73310105 | Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA) |
| Q47682926 | Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan |
| Q47205582 | Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study. |
| Q36907743 | Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis. |
| Q33706447 | B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients |
| Q60311701 | BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections |
| Q92566048 | Bilateral corneal perforation and iris prolapse as a complication non-peripheral ulcerative keratitis in a patient with fulminant granulomatosis with polyangiitis: a case report |
| Q54878489 | Bilateral dacryoadenitis as initial presentation of a locally aggressive and unresponsive limited form of orbital granulomatosis with polyangiitis. |
| Q50438045 | Bilateral deafness and unilateral facial nerve palsy as presenting features of Wegener's granulomatosis : a case report |
| Q41280510 | Bilateral idiopathic orbital inflammation 3 years before systemic Wegener's granulomatosis in a 7-year-old girl. |
| Q52647071 | Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis. |
| Q38647220 | Birmingham vasculitis activity score of more than 9.5 at diagnosis is an independent predictor of refractory disease in granulomatosis with polyangiitis. |
| Q36416541 | Blindness in a Sri Lankan woman with bilateral breast lumps: a case report |
| Q35455167 | Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study |
| Q78179285 | Bronchoalveolar lavage cell profiles in Wegener's granulomatosis |
| Q61974587 | C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats |
| Q35534202 | CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis |
| Q34431694 | CT of noninfectious granulomatous lung disease |
| Q54008575 | CUTANEOUS VASCULITIS. |
| Q35861654 | Cardiac Involvement in Granulomatosis with Polyangiitis |
| Q73233106 | Cardiac Wegener's granulomatosis masquerading as left atrial myxoma |
| Q35250782 | Cardiac involvement in Wegener's granulomatosis resistant to induction therapy |
| Q41334062 | Cardiac involvement in Wegener's granulomatosis. |
| Q37141445 | Case 2: A teenage boy with epistaxis |
| Q91734609 | Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis |
| Q57911986 | Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases |
| Q51688522 | Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experience. |
| Q64921536 | Characterisation of the nasal microbiota in granulomatosis with polyangiitis. |
| Q51064057 | Characteristics of granulomatosis with polyangiitis patients in Japan. |
| Q38951007 | Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis |
| Q38725556 | Chemokine receptor co-expression reveals aberrantly distributed TH effector memory cells in GPA patients |
| Q33262019 | Chest CT findings in pediatric Wegener's granulomatosis |
| Q38468941 | Childhood vasculitides in Turkey: a nationwide survey. |
| Q57294283 | Chronic large nasal bloody crusting and recurrent episcleritis: Limited granulomatosis with polyangiitis |
| Q39453185 | Circulating C3 levels predict renal and global outcome in patients with renal vasculitis |
| Q71675298 | Circulating adhesion molecules ICAM-1, VCAM-1 and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus |
| Q71943027 | Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome |
| Q41529152 | Classification and epidemiology of the vasculitides |
| Q38160767 | Classification of ANCA-associated vasculitis |
| Q38389842 | Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. |
| Q33514010 | Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood |
| Q47589357 | Clinical Factors Associated with the Diagnosis of Granulomatosis with Polyangiitis. |
| Q87416171 | Clinical aspects of granulomatosis with polyangiitis affecting the head and neck |
| Q40067987 | Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity |
| Q60921860 | Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis |
| Q37739043 | Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis |
| Q88917405 | Clinical features of different orbital manifestations of granulomatosis with polyangiitis |
| Q88185101 | Clinical mimics: an emergency medicine focused review of pneumonia mimics |
| Q38372499 | Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey |
| Q80505002 | Clinical relevance of anti-PR3 capture ELISA in diagnosing Wegener's granulomatosis |
| Q71691173 | Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides |
| Q24802072 | Clinical review: Vasculitis on the intensive care unit--part 1: diagnosis |
| Q27477923 | Clinical spectrum associated with positive ANCA titres in 94 consecutive patients: is there a relation with PR-3 negative c-ANCA and hypergammaglobulinaemia? |
| Q37775917 | Clinical value of 18F-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease |
| Q35552905 | Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosis |
| Q39655488 | Clinicopathologic characteristics of Weneger's granulomatosis: A report of three cases |
| Q35918556 | Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. |
| Q50649626 | Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schönlein purpura in adults. |
| Q73165903 | Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income, and interpersonal relationships: comment on the article by Hoffman et al |
| Q64101506 | Comparison of Radiological and Histological Findings of Lung Parenchyma in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
| Q74058927 | Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA) |
| Q53444752 | Compressive optic neuropathy caused by a paranasal sinus cyst of Wegener's granulomatosis. |
| Q67472696 | Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis |
| Q56907492 | Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells |
| Q38206402 | Critical appraisal of classification criteria for vasculitides |
| Q33917953 | Cutaneous nodules recurring in the legs ten years before the diagnosis of Wegener's granulomatosis |
| Q38119877 | Cutaneous vasculitis: a rheumatologist perspective |
| Q72138995 | Cyclophosphamide-induced hepatitis in Wegener's granulomatosis |
| Q42619998 | Dacryoadenitis with Ptosis and Diplopia as the Initial Presentation of Granulomatosis with Polyangiitis |
| Q40657889 | Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease |
| Q35901132 | Defining the nasal transcriptome in granulomatosis with polyangiitis (Wegener's). |
| Q55333498 | Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis. |
| Q34772654 | Design of the Wegener's Granulomatosis Etanercept Trial (WGET). |
| Q35549984 | Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis |
| Q45685779 | Developing a provisional definition of flare in patients with established gout |
| Q38514582 | Developing of Granulomatosis with Polyangiitis during Etanercept Therapy |
| Q42021046 | Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. |
| Q61799776 | Development of CT-based methods for longitudinal analyses of paranasal sinus osteitis in granulomatosis with polyangiitis |
| Q35759939 | Development of comprehensive disease assessment in systemic vasculitis |
| Q84675171 | Diagnostic Approach to ANCA-associated Vasculitides |
| Q55517294 | Diagnostic dilemmas of mechanical restriction of the medial rectus: A case report. |
| Q35178799 | Differences in CCR5 expression on peripheral blood CD4+CD28- T-cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis |
| Q54735882 | Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. |
| Q77755131 | Differential B- and T-cell activation in Wegener's granulomatosis |
| Q51561480 | Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes. |
| Q42034393 | Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener’s autoantigen |
| Q72432507 | Disease relapse in patients with ocular manifestations of Wegener granulomatosis |
| Q70704503 | Disseminated histoplasmosis with glomerulonephritis mimicking Wegener's granulomatosis |
| Q37185572 | Distinct eicosanoid profile in exhaled breath condensates from granulomatosis with polyangiitis (Wegener's) patients |
| Q43048976 | Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis |
| Q44805797 | Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology |
| Q46264782 | Drugs Implicated in Systemic Autoimmunity Modulate Neutrophil Extracellular Trap Formation. |
| Q81821059 | ENT Wegener's granulomatosis can hide severe central nervous system involvement |
| Q36684589 | EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis |
| Q24675246 | EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides |
| Q40492114 | Early diagnosis of vasculitides |
| Q47843978 | Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis. |
| Q33757209 | Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series |
| Q78024351 | Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy |
| Q40519831 | Endocarditis: the great mimic of rheumatic diseases |
| Q40638676 | Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls |
| Q50667664 | Epidemiology of Wegener's granulomatosis in northern Norway. |
| Q50609774 | Epidemiology of systemic vasculitis: changing incidence or definition? |
| Q34449076 | Epidemiology of the vasculitides |
| Q34663785 | Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis |
| Q70867166 | Erosive polyarthritis as presenting manifestation of Wegener's granulomatosis |
| Q46723069 | Erosive rhinitis resembling granulomatosis with polyangiitis (Wegener's granulomatosis) in an Anatolian shepherd dog. |
| Q40813743 | Estimating the incidence of connective tissue diseases and vasculitides in a defined population in Northern Savo area in 2010. |
| Q36745150 | Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography |
| Q83139948 | Exceptional osseous and meningeal spinal localization of ANCA-associated granulomatous vasculitis with hypertrophic spinal pachymeningitis |
| Q93111680 | Exclusively ocular and cardiac manifestation of granulomatosis with polyangiitis - a case report |
| Q75258800 | Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases |
| Q35553707 | Expression of matrix metalloproteinases in patients with Wegener's granulomatosis |
| Q40709360 | Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells |
| Q33928068 | External review and validation of the Swedish national inpatient register |
| Q33578596 | Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis |
| Q40334851 | Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts |
| Q28387801 | Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis |
| Q34965751 | Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis |
| Q44998018 | Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse |
| Q39709272 | Florid xanthelasmata (yellow lids) in orbital Wegener's granulomatosis |
| Q37138566 | Fulminant Wegener's granulomatosis presenting as epistaxis |
| Q47682561 | Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis |
| Q91668063 | Gastrointestinal Involvement in Granulomatosis with Polyangiitis: Case Report and Review |
| Q43730102 | Gastrointestinal involvement in granulomatosis with polyangiitis and microscopic polyangiitis: histological features and outcome |
| Q47911440 | Generalized Wegener's granulomatosis in an immunocompetent adult after cytomegalovirus mononucleosis and bacterial urinary tract infection |
| Q40459136 | Genetic variants in ANCA-associated vasculitis: a meta-analysis. |
| Q36093319 | Gingival hyperplasia as first sign of recurrence of granulomatosis with polyangiitis (Wegener's granulomatosis): case report and review of the literature |
| Q78124780 | Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis |
| Q26765803 | Granulomatosis With Polyangiitis in Otolaryngologist Practice: A Review of Current Knowledge |
| Q59160666 | Granulomatosis with Polyangiitis in Children |
| Q41623200 | Granulomatosis with Polyangiitis with Myocarditis and Ventricular Tachycardia |
| Q26748200 | Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations |
| Q44633495 | Granulomatosis with polyangiitis (Wegener's granulomatosis) diagnosed by transbronchial biopsy from stenotic portion of mainstem bronchus |
| Q38182988 | Granulomatosis with polyangiitis (Wegener's) presenting as the right ventricular masses: A case report and review of the literature. |
| Q39518123 | Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population. |
| Q40772374 | Granulomatosis with polyangiitis affecting the skull base and manifesting as spontaneous skull base osteomyelitis |
| Q41571653 | Granulomatosis with polyangiitis and associated pulmonary emphysema: Breathtaking vasculitis |
| Q37979678 | Granulomatosis with polyangiitis in childhood |
| Q55194478 | Granulomatosis with polyangiitis: a 17 year experience from a tertiary care hospital in Pakistan. |
| Q87916815 | Granulomatosis with polyangiitis: clinical course and outcome of 60 patients from a single center in South India |
| Q97541937 | Granulomatous diseases: Oral manifestations and recommendations |
| Q35082001 | Granulomatous vasculitis |
| Q51698690 | Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener's). |
| Q54213485 | HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study. |
| Q93052601 | Hepatitis B Virus-associated Vasculitis: Multiple Cavitary Masses in the Lung Mimicking Granulomatous Polyangiitis |
| Q24796029 | Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis |
| Q73498924 | High Plasma Levels of the Soluble Form of CD30 Activation Molecule Reflect Disease Activity in Patients with Wegener's Granulomatosis |
| Q44062249 | High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate |
| Q46531955 | High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide |
| Q33591595 | Horner's syndrome in Wegener's granulomatosis: report of four cases |
| Q82336252 | How could we make a diagnosis of Wegener's granulomatosis? |
| Q33692541 | Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with alpha-1-proteinase inhibitor |
| Q43999888 | Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody |
| Q45334607 | Hypogonadism in Wegener's granulomatosis |
| Q35651433 | IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis |
| Q36639341 | IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults |
| Q46385854 | IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis |
| Q79247275 | IgM and IgG autoantibodies from microscopic polyangiitis patients but not those with other small- and medium-sized vessel vasculitides recognize multiple endothelial cell antigens |
| Q44332240 | Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis |
| Q36489806 | Imaging of Wegener's granulomatosis |
| Q47980745 | Immune diffuse alveolar hemorrhage: a retrospective assessment of a diagnostic scale |
| Q35729575 | Immune mediated diseases and immune modulation in the neurocritical care unit |
| Q71730880 | Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration |
| Q60689249 | Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis |
| Q47594206 | Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener's granulomatosis and relapsing polychondritis. |
| Q40266045 | Impact of pre-existing co-morbidities on mortality in granulomatosis with polyangiitis: a cohort study |
| Q87609502 | Impact of renal involvement on survival in ANCA-associated vasculitis |
| Q34282077 | Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides |
| Q46546552 | Impaired Health-related Quality of Life in Patients Treated for Wegener’s Granulomatosis |
| Q41850112 | Impairment and Differential Expression of PR3 and MPO on Peripheral Myelomonocytic Cells with Endothelial Properties in Granulomatosis with Polyangiitis |
| Q52957882 | In situ evidence of pulmonary endothelial activation in patients with granulomatosis with polyangiitis and systemic sclerosis. |
| Q73310113 | In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG) |
| Q44068966 | In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase |
| Q46062830 | Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. |
| Q34156325 | Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins |
| Q64043729 | Incidence, prevalence, mortality and chronic renal damage of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a 20-year population-based cohort |
| Q46419664 | Increased expression of chemokines in patients with Wegener's granulomatosis - modulating effects of methylprednisolone in vitro |
| Q36245793 | Increased frequency of CCR4+ and CCR6+ memory T-cells including CCR7+CD45RAmed very early memory cells in granulomatosis with polyangiitis (Wegener's). |
| Q33767020 | Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA). |
| Q28345197 | Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment |
| Q35533314 | Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome |
| Q46187251 | Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener's granulomatosis |
| Q44116012 | Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis |
| Q33348350 | Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis |
| Q40646369 | Intermittent fevers, cough, and fatigue in a patient on replacement intravenous gammaglobulin |
| Q55334630 | Internal Auditory Canal Dural Enhancement in Granulomatosis with Polyangeitis Disease. |
| Q38738551 | International Consensus Statement on Allergy and Rhinology: Rhinosinusitis |
| Q57079504 | Irregular Cytokine Pattern of CD4+T Lymphocytes in Response toStaphylococcus aureusin Patients with Wegener's Granulomatosis |
| Q36958941 | Isolated vasculitis of the female genital tract: a case series and review of literature |
| Q38286390 | Issues associated with the Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitides: Reclassification of patients in the prospective cohort study of Remission Induction Therapy in Jap |
| Q43638601 | JC virus leukoencephalopathy complicating Wegener’s granulomatosis |
| Q42368413 | Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis |
| Q58620472 | Late onset of pANCA renal and pulmonary vasculitis in a girl affected by undifferentiated connective tissue disease |
| Q46846243 | Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab |
| Q79321828 | Limited Wegener's granulomatosis manifesting as malignant pyoderma with corneal melt |
| Q58218031 | Limited granulomatosis with polyangiitis in an adolescent with Crohn's disease on infliximab therapy: cause or coincidence? |
| Q45878080 | Long-term damage to the ENT system in Wegener's granulomatosis. |
| Q43416268 | Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre. |
| Q83408457 | Long-term outcome of acute and subacute myelopathies |
| Q43600194 | Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort |
| Q36936776 | Low dose radiotherapy as an effective treatment in a patient with solitary Wegener's granulomatosis resistant to systemic treatment - case report |
| Q33564565 | Lung involvement in childhood onset granulomatosis with polyangiitis |
| Q33706866 | M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis |
| Q37251075 | Management and Risk Reduction of Rheumatoid Arthritis in Individuals with Obstructive Sleep Apnea: A Nationwide Population-Based Study in Taiwan |
| Q97885719 | Massive hemoptysis: A rare case with uncommon presentation and rapid response - A case report |
| Q53078257 | Mean platelet volume can estimate the current vasculitis activity of microscopic polyangiitis. |
| Q71659432 | Methotrexate treatment of Wegener granulomatosis in children |
| Q42706595 | Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial. |
| Q83897905 | Microscopic polyangiitis complicated by cerebral haemorrhage |
| Q80697177 | Microscopic polyangiitis with sexual and reproductive system involvement: first description of a case |
| Q35548500 | Monocyte activation in patients with Wegener's granulomatosis |
| Q91668011 | Multiorgan Involvement with Severe Gastrointestinal System Manifestations in a Patient with Granulomatosis with Polyangiitis |
| Q38678874 | Multiple pulmonary nodules: a complex case of Wegener's granulomatosis |
| Q44497918 | Multiple, in part ulcerated nodules on the neck and legs of a 60 year old woman |
| Q92806786 | Multivariable index for assessing the activity and predicting all-cause mortality in antineutrophil cytoplasmic antibody-associated vasculitis |
| Q41231581 | Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets |
| Q33760303 | Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis. |
| Q38800560 | Nasal surgery in patients with systemic disorders |
| Q41729275 | Necrotizing RPGN with linear anti IgG deposits in a patient with history of granulomatosis with polyangiitis: a case report |
| Q33939212 | Necrotizing scleritis and peripheral ulcerative keratitis associated with Wegener's granulomatosis |
| Q36670626 | Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis |
| Q24679901 | Neurology of the vasculitides and connective tissue diseases |
| Q90667455 | Neutrophil to lymphocyte ratio at diagnosis can estimate vasculitis activity and poor prognosis in patients with ANCA-associated vasculitis: a retrospective study |
| Q35798078 | Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis |
| Q44767357 | New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes |
| Q36834892 | New horizons in renal vasculitis |
| Q37820047 | New pathophysiological insights and treatment of ANCA-associated vasculitis |
| Q91575072 | No Difference in Cognitive Dysfunction Among Patients with ANCA-Associated Vasculitis, Rheumatoid Arthritis or Chronic Kidney Disease |
| Q37859104 | Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS). |
| Q81096216 | Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis |
| Q33565287 | Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders |
| Q34102383 | Ocular disease in patients with ANCA-positive vasculitis |
| Q87151040 | Ocular vasculitis |
| Q33235941 | On the Wegener granulomatosis associated region on chromosome 6p21.3. |
| Q53531012 | One stroke--two triggers. |
| Q90480432 | Optic Neuritis |
| Q64903329 | Oral manifestations of granulomatosis with polyangiitis - Clinical and radiological assessment. |
| Q38235342 | Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings |
| Q46484775 | Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage |
| Q34977180 | Otolaryngologic manifestations of small vessel vasculitis |
| Q43820815 | Outcomes and organ dysfunctions of critically ill patients with systemic lupus erythematosus and other systemic rheumatic diseases |
| Q58885872 | PTPN22 R620W polymorphism in the ANCA-associated vasculitides |
| Q64971884 | PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases. |
| Q34106947 | PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation |
| Q38356477 | Pancreatic mass as an initial presentation of severe Wegener's granulomatosis |
| Q93004912 | Parotid Sinus Secondary to Granulomatosis with Polyangiitis: A Case Report |
| Q47299381 | Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis. |
| Q82698398 | Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells |
| Q84830207 | Pediatric Wegener's granulomatosis with oral ulcers and progressive periodontitis: a case report |
| Q50910168 | Pediatric granulomatosis with polyangiitis exhibiting prominent central nervous system symptoms. |
| Q83098490 | Periorbital swelling and nasal congestion in a 31-year-old man |
| Q35748061 | Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis |
| Q45282440 | Peripheral neuropathy as initial manifestation of primary systemic vasculitides |
| Q36226668 | Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis |
| Q39677913 | Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. |
| Q51981044 | Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis. |
| Q36530185 | Pharmacological therapy for Wegener's granulomatosis. |
| Q48316024 | Pilot study to assess the frequency of fibromyalgia, depression, and sleep disorders in patients with granulomatosis with polyangiitis (Wegener's). |
| Q39328177 | Pituitary dysfunction in granulomatosis with polyangiitis. |
| Q36152127 | Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. |
| Q74185352 | Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis |
| Q41099072 | Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality |
| Q38221817 | Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases |
| Q40041740 | Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. |
| Q43779444 | Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus |
| Q38232599 | Presentation and initial assessment of ENT problems in patients with granulomatosis with polyangiitis (Wegener's). |
| Q37605666 | Prevalence and incidence of Wegener's granulomatosis in the UK general practice research database |
| Q43546669 | Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. |
| Q58773547 | Primary Vasculitis in Childhood: GPA and MPA in Childhood |
| Q47863831 | Primary systemic vasculitis: clinical features and mortality |
| Q36119765 | Problems in classifying vasculitis in children |
| Q24595974 | Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival |
| Q36152477 | Prolonged B cell depletion with rituximab is effective in treating refractory pulmonary granulomatous inflammation in granulomatosis with polyangiitis (GPA). |
| Q41733954 | Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis. |
| Q40096353 | Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis. |
| Q24807322 | Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis |
| Q71917546 | Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3 |
| Q41519660 | Pulmonary vasculitis: classification, clinical features, and management |
| Q36839521 | Pulmonary-renal syndromes |
| Q49679461 | Pyoderma Gangrenosum-associated Granulomatosis with Polyangitis: A Case Report and Literature Review |
| Q35310520 | Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease |
| Q98772533 | Rare Presentation of Severely Limited Granulomatosis With Polyangiitis Manifesting With Orbital Wall Destruction: Literature Review and Case Report |
| Q51542464 | Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology. |
| Q40848895 | Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies |
| Q50850119 | Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease. |
| Q80101276 | Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression |
| Q46006970 | Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab. |
| Q43136893 | Recurrence of anti-neutrophil cytoplasmic antibody-associated vasculitis in appropriately immunosuppressed renal transplant patients: a discussion of two cases |
| Q50049397 | Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis |
| Q45976155 | Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis. |
| Q45840349 | Regulatory B cells in ANCA-associated vasculitis. |
| Q36765422 | Regulatory and effector B cell cytokine production in patients with relapsing granulomatosis with polyangiitis. |
| Q71457761 | Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A |
| Q33566003 | Relapsing polychondritis as a secondary phenomenon of primary systemic vasculitis |
| Q28386741 | Relation between asymptomatic proteinase 3 antibodies and future granulomatosis with polyangiitis |
| Q46878564 | Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides |
| Q89171720 | Relationship of ocular presentation in granulomatosis with polyangiitis to autoantibodies and disease activity |
| Q47945583 | Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis |
| Q33897549 | Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience |
| Q40295571 | Renal vasculitis presenting with acute kidney injury |
| Q44641551 | Retro-orbital granuloma associated with granulomatosis with polyangiitis: a series of nine cases. |
| Q34799715 | Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis |
| Q94547418 | Reuma.pt/vasculitis - the Portuguese vasculitis registry |
| Q48337165 | Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor. |
| Q47656725 | Risk factors and treatment of pneumothorax secondary to granulomatosis with polyangiitis: a clinical analysis of 25 cases |
| Q56243435 | Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study |
| Q40513822 | Risk of Myocardial Infarction and Stroke in Patients With Granulomatosis With Polyangiitis (Wegener's): A Population-Based Study |
| Q37731877 | Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment |
| Q37144563 | Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial |
| Q47581564 | Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center |
| Q53481600 | Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide. |
| Q48113733 | Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's). |
| Q45261256 | Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis |
| Q39223794 | Rituximab-a drug with many facets and cures: a treatment for acute refractory hypoxemic respiratory failure secondary to severe granulomatosis with polyangiitis |
| Q36424005 | Role of gingival manifestation in diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis) |
| Q73141939 | Role of thoracic surgery and interventional bronchoscopy in Wegener's granulomatosis |
| Q50076914 | S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis |
| Q48021187 | Saddle nose deformity and septal perforation in granulomatosis with polyangiitis. |
| Q40479082 | Saddle-nose and bilateral cauliflower ear deformities with pyoderma gangrenosum-like ulcers, cavitary pulmonary lesions, digital gangrene and pulselessness in a young female. |
| Q34595156 | Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept |
| Q33375927 | Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases |
| Q36683385 | Salivary gland involvement as initial presentation of Wegener's disease |
| Q51573223 | Sellar Wegener Granulomatosis Masquerading as Cabergoline-Resistant Prolactinoma. |
| Q47144294 | Serum 25-hydroxyvitamin D levels in patients with Granulomatosis with Polyangiitis: association with respiratory infection |
| Q35554235 | Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction |
| Q90037970 | Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis |
| Q40127582 | Severe destructive nasopharyngeal granulomatosis with polyangiitis with superimposed skull base Pseudomonas aeruginosa osteomyelitis. |
| Q58004245 | Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's) |
| Q64971545 | Sigmoid colon perforation in the patient with granulomatosis with polyangiitis. |
| Q33372911 | Single cell analysis of B lymphocytes from Wegener's granulomatosis: B cell receptors display affinity maturation within the granulomatous lesions |
| Q39136235 | Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with microscopic polyangiitis in the northern Han Chinese population |
| Q37407205 | Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases |
| Q46521571 | Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission |
| Q51155098 | Skewing toward Treg and Th2 responses is a characteristic feature of sustained remission in ANCA-positive granulomatosis with polyangiitis. |
| Q34628409 | Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort |
| Q35555592 | Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus. |
| Q67888274 | Splenic necrosis in Wegener's granulomatosis |
| Q85118772 | Spontaneous perirenal hematoma due to Wegener’s granulomatosis after initiation of immunosuppressant |
| Q37045538 | Spontaneous pneumothorax in Wegener's granulomatosis: a case report |
| Q36816527 | Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography |
| Q35554748 | Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis |
| Q73465636 | Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis |
| Q41126772 | Staphylococcus Aureus carriage and long-term Rituximab treatment for Granulomatosis with polyangiitis. |
| Q35725735 | Successful Combination Therapy with Rituximab and Glucocorticoids for Autoimmune Optic Neuropathy |
| Q59339831 | Successful rituximab treatment of granulomatosis with polyangiitis with cranial neuropathies |
| Q41907067 | Successful treatment of granulomatosis with polyangiitis with hydropneumothorax using corticosteroids and immunosuppressant |
| Q42955954 | Successful treatment of meningeal involvement in Wegener's granulomatosis with infliximab |
| Q73657609 | Surgical pathology of non-neoplastic lung disease |
| Q37687435 | Survival of patients with Wegener's granulomatosis diagnosed in Finland in 1981-2000. |
| Q41529174 | Systemic necrotizing vasculitis |
| Q39687231 | Systemic vasculitis: a dual diagnosis? |
| Q72893742 | T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG) |
| Q54004687 | T cell receptor (TCR) V gene usage in patients with systemic necrotizing vasculitis |
| Q33885156 | Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group |
| Q41864176 | Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy |
| Q37247168 | The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis |
| Q36856761 | The Churg-Strauss syndrome: An unusual presentation |
| Q47547545 | The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis. |
| Q64075235 | The MRZ-Reaction and Specific Autoantibody Detection for Differentiation of ANA-Positive Multiple Sclerosis From Rheumatic Diseases With Cerebral Involvement |
| Q51299524 | The Missing Antibody: The Pitfalls of ANCA Testing. |
| Q26740451 | The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries |
| Q37778584 | The Pulmonary Vasculitides |
| Q38547761 | The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis |
| Q47711352 | The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis |
| Q39803893 | The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis |
| Q27473557 | The clinical relevance of ANCA in vasculitis |
| Q27469302 | The clinical utility of ANCA positivity |
| Q51310336 | The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener's): a retrospective study of 45 patients in Korea. |
| Q36301691 | The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis |
| Q40053425 | The epidemiology of ANCA associated vasculitis in Olmsted County, Minnesota (USA): a 20 year population-based study. |
| Q39907297 | The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey |
| Q51871294 | The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI). |
| Q37670296 | The histological assessment of cutaneous vasculitis |
| Q36887036 | The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study |
| Q37049174 | The last classification of vasculitis |
| Q40884383 | The obstructive siblings: Relapsing polychondritis without chondritis? |
| Q34523517 | The presentation and management of granulomatosis with polyangiitis (Wegener's Granulomatosis) in the pediatric airway |
| Q47588799 | The psychological burden of peanut allergy as perceived by adults with peanut allergy and the parents of peanut-allergic children |
| Q35002495 | The role of conjunctival biopsy in the diagnosis of granulomatosis with polyangiitis |
| Q83119894 | The use of Campath in severe peripheral ulcerative keratitis associated with Wegener's granulomatosis |
| Q50050942 | The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. |
| Q34267966 | Therapeutic strategies in systemic necrotizing vasculitides |
| Q33790855 | Thrombosis in small and medium-sized pulmonary arteries in Wegener's granulomatosis: a confocal laser scanning microscopy study. |
| Q38695974 | Time to focus on outcome assessment tools for childhood vasculitis |
| Q43715022 | Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. |
| Q40593657 | Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro. |
| Q36195111 | Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's): A Report on 26 Cases |
| Q33921278 | Transcription of proteinase 3 and related myelopoiesis genes in peripheral blood mononuclear cells of patients with active Wegener's granulomatosis |
| Q71917500 | Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin |
| Q41476938 | Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy |
| Q74514106 | Treatments for systemic vasculitides |
| Q38233296 | Tuberculous mastitis presenting as a lump: a mimicking disease in a pregnant woman case report and review of literature |
| Q41829816 | Two cases of extrapulmonary onset granulomatosis with polyangiitis which caused diffuse alveolar haemorrhage. |
| Q48793099 | Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener's). |
| Q92962975 | Unclassified Vasculitis with Episcleritis, Thrombophlebitis, Deep Vein Thrombosis, Pulmonary Vasculitis, and Intracranial Vasculitis: An Autopsy Case Report |
| Q48383577 | Unexpectedly difficult intubation caused by subglottic stenosis in Wegener's granulomatosis |
| Q64955885 | Unraveling the identity of FoxP3+ regulatory T cells in Granulomatosis with Polyangiitis patients. |
| Q78576627 | Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease |
| Q28069897 | Updates in ANCA-associated vasculitis |
| Q40086520 | Upper Gastrointestinal Bleeding as the First Manifestation of Wegener's Granulomatosis. |
| Q51660911 | Ureteral stenosis as the sole manifestation of Wegener's granulomatosis. |
| Q31046440 | Use of SNOMED CT to represent clinical research data: a semantic characterization of data items on case report forms in vasculitis research |
| Q44427248 | Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener’s granulomatosis: extended follow-up and rate of relapse |
| Q31137060 | Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3. |
| Q90024217 | Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement |
| Q36886158 | Value of opinion by oral physician in diagnosing Wegener's granulomatosis |
| Q35555099 | Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off? |
| Q71581592 | Vasculitis |
| Q48216968 | Vasculitis in the Central Nervous System |
| Q70537502 | Vasculitis masquerading as vasculitis |
| Q34983159 | Vasculitis-like hemorrhagic retinal angiopathy in Wegener's granulomatosis |
| Q34990085 | Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis |
| Q38284032 | Vasculitis: do we know more to classify better? |
| Q24304502 | Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway |
| Q35787303 | Wegener granulomatosis in childhood and adolescence |
| Q42532324 | Wegener's Granulomatosis with Fungal Lung Infection in a Child |
| Q42138539 | Wegener's disease presenting with occipital condyle syndrome |
| Q74456726 | Wegener's granulomatosis |
| Q41641740 | Wegener's granulomatosis and ANCA syndromes |
| Q46138263 | Wegener's granulomatosis and microscopic polyangiitis |
| Q38064866 | Wegener's granulomatosis and mucoromycosis: A case study and review of literature |
| Q34318518 | Wegener's granulomatosis and the Churg-Strauss syndrome |
| Q50758742 | Wegener's granulomatosis associated with antiphospholipid syndrome. |
| Q40870666 | Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases |
| Q43220373 | Wegener's granulomatosis detected initially by integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography |
| Q44264066 | Wegener's granulomatosis diagnosed by testicular biopsy |
| Q67823951 | Wegener's granulomatosis disclosed by clinical symptoms of Horton's disease |
| Q41258599 | Wegener's granulomatosis followed by development of sarcoidosis |
| Q37256621 | Wegener's granulomatosis in Finland in 1981-2000: clinical presentation and diagnostic delay |
| Q37828155 | Wegener's granulomatosis in Finland in 1981-2000: risk of dialysis-dependent renal disease |
| Q42088670 | Wegener's granulomatosis in a young patient preceded by localized cutaneous manifestations |
| Q67888268 | Wegener's granulomatosis in childhood |
| Q42068414 | Wegener's granulomatosis in which rheumatoid factor was useful for evaluating the disease status: a case report |
| Q42204588 | Wegener's granulomatosis mimicking inflammatory bowel disease and presenting with chronic enteritis |
| Q35583483 | Wegener's granulomatosis of nose: a case report |
| Q53537915 | Wegener's granulomatosis of the breast. |
| Q44524613 | Wegener's granulomatosis of the prostate gland |
| Q41705016 | Wegener's granulomatosis presenting as a recurrence of chronic otitis media |
| Q82831180 | Wegener's granulomatosis presenting as a thyroid mass |
| Q40379069 | Wegener's granulomatosis presenting with life-threatening lung hemorrhage in a 7-year-old child |
| Q35687809 | Wegener's granulomatosis presenting with pachymeningitis: clinical and imaging remission by rituximab |
| Q74446867 | Wegener's granulomatosis upper respiratory tract and pulmonary radiographic manifestations in 30 cases with pathogenetic consideration |
| Q80606536 | Wegener's granulomatosis with massive gastrointestinal hemorrhage due to jejunal and colonic involvement: report of a case |
| Q37994863 | Wegener's granulomatosis with pulmonary fungal infection: a case report and brief review |
| Q28393433 | Wegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunity |
| Q38072743 | Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment |
| Q46857224 | Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey |
| Q53201543 | Wegener's granulomatosis: epidemiological and clinical features in a South Australian study. |
| Q45099806 | Wegener's granulomatosis: experience from a Brazilian tertiary center |
| Q43842444 | Wegener's granulomatosis: inflammatory cells and markers of repair and fibrosis in renal biopsies--a clinicopathological study |
| Q33957306 | What stuff is this! A historical perspective on fibrinoid necrosis |
| Q86270688 | [ANCA-associated vasculitis] |
| Q86911314 | [ANCA-associated vasculitis] |
| Q81578118 | [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement] |
| Q83475678 | [Expectations of rheumatologists on imaging results] |
| Q78089574 | [Features of tomodensitometry in the development of pleuropulmonary lesions related to Wegener's granulomatosis] |
| Q50699972 | [Foudroyant course of a therapy resistent Wegener's granulomatosis with negative c-ANCA]. |
| Q81161151 | [How can the diagnostic value of head and neck biopsies be increased in Wegener's granulomatosis: a clinicopathologic study of 49 biopsies in 21 patients] |
| Q82805259 | [Noninvasive mechanical ventilation with a helmet in a patient with acute respiratory failure due to alveolar bleeding (Wegener granulomatosis)] |
| Q73173887 | [Systemic necrotizing vasculitides: classifications and therapeutic strategies] |
| Q79331067 | [Ureteral stenosis in Wegener's granulomatosis. Case report] |
| Q73907142 | [Wegener's granulomatosis - a case report] |
| Q80446924 | [Wegener's granulomatosis in the head and neck region] |
| Q70828509 | c-ANCA as a marker of Wegener's disease |
| Q40520319 | p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report |
| Q53861550 | von Willebrand factor antigen and adhesive molecules in Wegener's granulomatosis and microscopic polyangiitis. |
Search more.